See also this year's filing and all EDGAR filings for this company.
PDF Report 0001348911_2022_Kalvista_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001348911, Kalvista Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 264,264,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,791,000 |
| 3 | remainder_Assets | 5,958,000 |
| 4 | LiabilitiesCurrent | 9,774,000 |
| 5 | LiabilitiesNoncurrent | 5,046,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,663,541 |
| 9 | ResearchAndDevelopmentExpense | 41,652,696 |
| 10 | remainder_Expenses | -73,169 |
| 11 | remainder_Revenues | -21,905,341 |
| 12 | remainder_NetIncome | 11,590,601 |
| 13 | remainder_ComprehensiveNetIncome | 327,740 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 272,013,000 |
| 1 | Liabilities | 14,820,000 |
| 2 | Expenses | 57,243,068 |
| 3 | Revenues | -21,905,341 |
| 4 | StockholdersEquity | 257,193,000 |
| 5 | NetIncome | -67,557,808 |
| 6 | ComprehensiveNetIncome | -67,393,938 |
| 7 | BaseVar | 188,949,875 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.44 |
| 9 | EconomicCapitalRatio | 3.99 |
Edgar->Model Mapping
Feature Distribution
Change over Time
